Long-term alterations in cellular and humoral markers associated with senescence and regeneration in patients at high cardiovascular risk

Cellular senescence and the associated secretory phenotype may contribute to chronic inflammation, endothelial dysfunction, and impaired tissue repair, thereby limiting tissue regenerative capacity. This issue is of particular relevance to patients with cardiovascular disease who have been exposed to additional adverse stressors during the COVID-19 pandemic. Objective. To compare long-term changes in cellular and humoral markers associated with senescence and regeneration in patients at high cardiovascular risk who experienced acute cardiac events before and during the COVID-19 pandemic. Methods. The study included 90 patients allocated to three groups of 30: patients who had experienced myocardial infarction before the COVID-19 pandemic; patients with myocardial infarction accompanied by COVID-19 during the pandemic; and patients who had experienced myocardial infarction during the pandemic without concomitant COVID-19 at the time of hospitalization. At 61-73 months after the acute event, flow cytometry was used to determine the relative proportions of leukocytes expressing senescence-associated beta-galactosidase, CD34+ hematopoietic progenitor cells, CD309+ endothelial progenitor cells, and CD31hi circulating endothelial cells in peripheral blood. The proportion of cells containing senescence-associated heterochromatin foci was assessed in blood smears by fluorescence microscopy. The cytokinesis-block micronucleus assay was performed in short-term cultures of peripheral blood mononuclear cells. Serum concentrations of IL-1β, IL-6, ICAM-1, VCAM-1, TNF-α, von Willebrand factor (vWF), tissue plasminogen activator (tPA), lactate dehydrogenase A (LDHA), and endothelial nitric oxide synthase (eNOS) were measured using enzyme-linked immunosorbent assays. Results. The most pronounced between-group differences were observed in cellular parameters. Patients in both pandemic-period groups had higher proportions of SA-β-gal-positive leukocytes, CD309+ progenitor cells, and CD31hi circulating endothelial cells. The group with concomitant COVID-19 also showed a higher proportion of CD34+ hematopoietic progenitor cells in peripheral blood, together with increased frequencies of micronuclei and apoptotic cells in mononuclear cell cultures. In contrast, among the serum humoral markers, statistically significant between-group differences were detected only for IL-1β and von Willebrand factor. Conclusions. Long-term differences in selected cellular and humoral parameters associated with senescence, regeneration, and hemostasis were identified in patients following myocardial infarction. These differences varied according to the presence of concomitant COVID-19 and exposure to stress-related factors during the pandemic, highlighting the importance of a comprehensive assessment of these parameters in patients at high cardiovascular risk.

Authors

Institutions

Publication Details

Journal
Cell and Organ Transplantology
Published
2026-11-20
DOI
https://doi.org/10.22494/cot.v14-2.196
Primary Topic
Telomeres, Telomerase, and Senescence
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Long-term alterations in cellular and humoral markers associated with senescence and regeneration in patients at high cardiovascular risk

O. A. Skarzhevskyi, Alexander N. Parkhomenko, D. V. Khomiakov, Alina Ustymenko et al.
Cell and Organ Transplantology
Telomeres, Telomerase, and Senescence
article

Long-term alterations in cellular and humoral markers associated with senescence and regeneration in patients at high cardiovascular risk

O. A. Skarzhevskyi, Alexander N. Parkhomenko, D. V. Khomiakov, Alina Ustymenko, Oleg Tsupykov, V. M. Kyryk
article en

Abstract

Cellular senescence and the associated secretory phenotype may contribute to chronic inflammation, endothelial dysfunction, and impaired tissue repair, thereby limiting tissue regenerative capacity. This issue is of particular relevance to patients with cardiovascular disease who have been exposed to additional adverse stressors during the COVID-19 pandemic. Objective. To compare long-term changes in cellular and humoral markers associated with senescence and regeneration in patients at high cardiovascular risk who experienced acute cardiac events before and during the COVID-19 pandemic. Methods. The study included 90 patients allocated to three groups of 30: patients who had experienced myocardial infarction before the COVID-19 pandemic; patients with myocardial infarction accompanied by COVID-19 during the pandemic; and patients who had experienced myocardial infarction during the pandemic without concomitant COVID-19 at the time of hospitalization. At 61-73 months after the acute event, flow cytometry was used to determine the relative proportions of leukocytes expressing senescence-associated beta-galactosidase, CD34+ hematopoietic progenitor cells, CD309+ endothelial progenitor cells, and CD31hi circulating endothelial cells in peripheral blood. The proportion of cells containing senescence-associated heterochromatin foci was assessed in blood smears by fluorescence microscopy. The cytokinesis-block micronucleus assay was performed in short-term cultures of peripheral blood mononuclear cells. Serum concentrations of IL-1β, IL-6, ICAM-1, VCAM-1, TNF-α, von Willebrand factor (vWF), tissue plasminogen activator (tPA), lactate dehydrogenase A (LDHA), and endothelial nitric oxide synthase (eNOS) were measured using enzyme-linked immunosorbent assays. Results. The most pronounced between-group differences were observed in cellular parameters. Patients in both pandemic-period groups had higher proportions of SA-β-gal-positive leukocytes, CD309+ progenitor cells, and CD31hi circulating endothelial cells. The group with concomitant COVID-19 also showed a higher proportion of CD34+ hematopoietic progenitor cells in peripheral blood, together with increased frequencies of micronuclei and apoptotic cells in mononuclear cell cultures. In contrast, among the serum humoral markers, statistically significant between-group differences were detected only for IL-1β and von Willebrand factor. Conclusions. Long-term differences in selected cellular and humoral parameters associated with senescence, regeneration, and hemostasis were identified in patients following myocardial infarction. These differences varied according to the presence of concomitant COVID-19 and exposure to stress-related factors during the pandemic, highlighting the importance of a comprehensive assessment of these parameters in patients at high cardiovascular risk.

Cell and Organ TransplantologyVol. 14(2)
D. F. Chebotarev State Institute of Gerontology of the National Academy of Medical Sciences of Ukraine (UA), National Academy of Medical Sciences of Ukraine (UA), Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine (UA), National Scientific Center "M.D. Strazhesko Institute of Cardiology" (UA)
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon